A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for multiple sclerosis https://www.medrxiv.org/content/10.1101/2022.11.11.22282226
A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for multiple sclerosis https://www.medrxiv.org/content/10.1101/2022.11.11.22282226